IL2 and neoplasm: Tumor cells upregulate CD38 to produce adenosine, which encourages metastasis by binding to tumor A2B receptors, causing defects in the T-cell-signaling pathway via the interruption of the IL2-induced phosphorylation of STAT 5a and STAT5b in primary and CTLL-2 T cells.